EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Gut Microbiota in Modulating Immune Signaling Pathways in Autoimmune Diseases

Nada Khairi Younis, Karar H Alfarttoosi, Gaurav Sanghvi, R Roopashree, Aditya Kashyap, T Krithiga, Waam Mohammed Taher, Mariem Alwan, Mahmood Jasem Jawad, Ali M Ali Al-Nuaimi

NeuroMolecular Medicine · 17.09.2025 · 27 (1)

DOI: 10.1007/s12017-025-08883-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift NeuroMolecular Medicine, online erschienen am 17.09.2025. Verfasst von Nada Khairi Younis und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Alnoor University, Mosul, Iraq. nada_khairi_younis@hotmail.com. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Autoimmune Diseases, Signal Transduction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 159 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The composition of intestinal microbial communities plays a crucial role in maintaining immune homeostasis, influencing both innate and adaptive immune responses. Growing evidence indicates that bidirectional communication between gut bacteria and host immune cells contributes to the development of autoimmune diseases. Disruptions in microbial diversity, known as dysbiosis, are linked to an increased susceptibility to autoimmune disorders such as rheumatoid arthritis (RA), multiple sclerosis (MS), and lupus erythematosus. This review examines the mechanistic connections between microbial dysregulation and abnormal immune activation, focusing on key signaling pathways. Pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), Janus kinase/signal transducers and activators of transcription (JAK/STAT), and Toll-like receptor (TLR) networks act as immunological gatekeepers, and their dysregulation-induced by microbial metabolites or shifts in microbial composition-can lead to chronic inflammation and the breakdown of self-tolerance. Additionally, bacterial fermentation products, including short-chain fatty acids (SCFAs), exert immunomodulatory effects by influencing T-cell differentiation and cytokine profiles. Emerging therapeutic strategies targeting microbial restoration, such as precision probiotics, microbiota transplantation, and tailored nutritional interventions, aim to restore immune balance. This review underscores the gut microbiota as a dynamic regulator of immune signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAutoimmune DiseasesSignal TransductionHumansDysbiosisAnimalsFatty Acids, VolatileToll-Like ReceptorsNF-kappa BSTAT Transcription FactorsJanus KinasesProbioticsArthritis, Rheumatoid

Stichwörter der Autor:innen

Autoimmune diseasesDysbiosisGut microbiotaImmune modulationImmune signaling

Substanzen

Fatty Acids, VolatileToll-Like ReceptorsNF-kappa BSTAT Transcription FactorsJanus Kinases

Autor:innen und Institutionen

  • College of Pharmacy, Alnoor University, Mosul, Iraq. nada_khairi_younis@hotmail.com.
  • College of Pharmacy, Ahl Al Bayt University, Kerbala, Iraq.
  • Department of Microbiology, Marwadi University Research Center, Faculty of Science, Marwadi University, Rajkot, Gujarat, 360003, India.
  • Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
  • Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, 140401, India.
  • Department of Chemistry, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.

Zitieren

APA

Younis, N. K., Alfarttoosi, K. H., Sanghvi, G., Roopashree, R., Kashyap, A., Krithiga, T., Taher, W. M., Alwan, M., Jawad, M. J., & Al-Nuaimi, A. M. A. (2025). The Role of Gut Microbiota in Modulating Immune Signaling Pathways in Autoimmune Diseases. NeuroMolecular Medicine, 27(1). https://doi.org/10.1007/s12017-025-08883-9

Vancouver

Younis NK, Alfarttoosi KH, Sanghvi G, Roopashree R, Kashyap A, Krithiga T, et al. The Role of Gut Microbiota in Modulating Immune Signaling Pathways in Autoimmune Diseases. NeuroMolecular Medicine. 2025;27(1). doi:10.1007/s12017-025-08883-9

BibTeX
@article{Younis2025,
  author = {Younis, Nada Khairi and Alfarttoosi, Karar H and Sanghvi, Gaurav and Roopashree, R and Kashyap, Aditya and Krithiga, T and Taher, Waam Mohammed and Alwan, Mariem and Jawad, Mahmood Jasem and Al-Nuaimi, Ali M Ali},
  title = {The Role of Gut Microbiota in Modulating Immune Signaling Pathways in Autoimmune Diseases},
  journal = {NeuroMolecular Medicine},
  year = {2025},
  volume = {27},
  number = {1},
  doi = {10.1007/s12017-025-08883-9}
}
Kostenlos starten →